Table 4.
Characteristic | rs8193 genotype | OR (95% CI) | P value | |
---|---|---|---|---|
TT n=24 | CC+CT n=144 | |||
n (%) | n (%) | |||
Distal metastasis | 0.899* | |||
No | 13 (54.17) | 80 (55.56) | ||
Yes | 11 (45.83) | 64 (44.44) | ||
Regional lymph node spread | 4.896 (1.985-12.076) | <0.001* | ||
No | 13 (54.17) | 28 (19.44) | ||
Yes | 11 (45.83) | 116 (80.56) | ||
Stage | 0.241 (0.084-0.688) | 0.011** | ||
I | 7 (29.17) | 13 (9.03) | ||
II, III and IV | 17 (70.83) | 131 (90.97) | ||
II | 2 (8.33) | 30 (20.83) | - | 0.254** |
I, III and IV | 22 (91.67) | 114 (79.19) | ||
III | 6 (25) | 48 (33.33) | - | 0.487** |
I, II and IV | 18 (75) | 96 (66.67) | ||
IV | 9 (37.50) | 53 (36.81) | - | 0.998** |
I, II and III | 15 (62.50) | 91 (63.19) | ||
*; Chi-square test, **; Fisher’s exact test, OR; Odds ratio, and CI; Confidence interval.